Somatostatin analog with a cyclic octapeptide structure. Exhibits high affinity for SSTR2 and inhibits growth hormone secretion. Long-acting formulations may be administered once every 2–4 weeks. Used for acromegaly and neuroendocrine tumors. Research-grade material is used in studies of somatostatin receptors, long-acting formulations, and cancer therapy.
Basic Information
- Product Name
- Lanreotide
- Catalog No.
- P-32017
- CAS No.
- —
- Sequence
- H-[d2Nal]CY[dW]KVCT-NH2 {cyclo=disulfide:2-7}
- Molecular Formula
- C41H59N9O10S2
- Molecular Weight
- 1211.43
Peptide Depictor
8 aa
Mouse wheel or pinch to zoom, drag to pan, click to show residue structure
Natural AA
Non-natural AA
Linker-like
Side-chain mod
Unknown
Acidic
Basic
Hydrophobic
Aromatic
Modified
Disulfide bond
Cyclization bond
AI-Assisted Peptide Property AnalysisShowHide
Sequence Overview
H-[d2Nal]CY[dW]KVCT-NH2 {cyclo=disulfide:2-7}
Length
8.000
Molecular Weight
1095.47 Da
Monoisotopic Mass
1095.47 Da
Estimated Net Charge
1.000
pI
8.990
Hydrophobicity GRAVY
0.4130
Physicochemical Properties
Basic Residue Ratio
13%
Acidic Residue Ratio
0%
Aromatic Residue Ratio
13%
Cys Count
2.000
Oxidation-Risk Residues
2.000
Asp-Gly / Asn-Gly
0.000
Solubility Analysis
Water Solubility
Good
Acidic Aqueous Compatibility
Suitable
Basic Aqueous Compatibility
Use with caution
DMSO Solubility Tendency
Moderate
Recommended Delivery Form
free
- 含多个Cys，溶解和氧化状态需同步控制
Calculation Parameters
Calculated parameters are model predictions for research design, candidate comparison, and project evaluation only. They are not experimental measurements or final synthesis outcomes.
| Property | Parameter | Value | Result |
|---|---|---|---|
| Hemolysis Risk | score threshold | 0.03279————0.5640 | Non-hemolytic |
| Non-Fouling | score threshold | 0.04711————0.3892 | Fouling |
| Solubility | score threshold | 0.9860————0.3290 | Soluble |
| Cell-Penetrating Potential | score threshold | 0.7322————0.5028 | Cell-Penetrating |
| Toxicity Risk | score threshold | 0.3419————0.4900 | Non-Toxic |
| PAMPA Passive Membrane Permeability | predicted value | -6.669 | PAMPA prediction: lower passive membrane permeability |
| Caco-2 Permeability | predicted value | -5.843 | Caco-2 prediction: higher cell-model permeability |
| Half-Life Model Output | model output | 0.8688 | Model output only, not in-vivo half-life |